52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Clinical trial NCT02120027 · TERMINATED
Trial details
- NCT number
- NCT02120027
- Sponsor
- Menarini Group
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2015-11-01
- Enrollment
- 558
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.